Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond

Yuichi Saito; Kazuma Oyama; Kenichi Tsujita; Satoshi Yasuda; Yoshio Kobayashi

doi:10.1016/j.jjcc.2022.07.003

Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond

J Cardiol. 2023 Feb;81(2):168-178. doi: 10.1016/j.jjcc.2022.07.003. Epub 2022 Jul 23.

Authors

Yuichi Saito¹, Kazuma Oyama², Kenichi Tsujita³, Satoshi Yasuda², Yoshio Kobayashi⁴

Affiliations

¹ Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan. Electronic address: saitoyuichi1984@gmail.com.
² Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
³ Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
⁴ Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

PMID: 35882613
DOI: 10.1016/j.jjcc.2022.07.003

Abstract

Owing to recent advances in early reperfusion strategies, pharmacological therapy, standardized care, and the identification of vulnerable patient subsets, the prognosis of acute myocardial infarction has improved. However, there is still considerable room for improvement. This review article summarizes the latest evidence concerning clinical diagnosis and treatment of acute myocardial infarction.

Keywords: Acute myocardial infarction; Medical therapy; Percutaneous coronary intervention.

Publication types

Review

MeSH terms

Humans
Myocardial Infarction* / diagnosis
Myocardial Infarction* / therapy
Myocardial Reperfusion
Myocardial Revascularization
Percutaneous Coronary Intervention*
Prognosis
Thrombolytic Therapy
Treatment Outcome